SEC Form 4 · accession 0001209191-16-108192
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Hall
Officer — EVP, CSO, Global Head of R&D
Period of report
Mar 11, 2016
Accepted (ET)
Mar 14, 2016 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Mar 11, 2016 | F | 626 | $41.67 | D | 4,826 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Dr. Hall's March 11, 2014 grant of restricted stock units (RSUs) vested on March 11, 2016.
- F2These shares represent stock withheld by Endo International plc to satisfy Dr. Hall's tax withholding obligations on shares acquired upon vesting of RSUs.
- F3$41.67 represents the vesting price, which is the average of the high and low share price on March 11, 2016.